NCT05603546View on ClinicalTrials.gov

A Prospective, Multicenter, Observational Study on the Treatment of Chronic Common Femoral Artery Bifurcation Occlusion

RecruitingOBSERVATIONAL

Enrollment

300

Participants

Timeline

Start Date

February 15, 2022

Primary Completion Date

February 14, 2024

Study Completion Date

February 14, 2026

Conditions

Common Femoral Artery Occlusive Disease

Trial Locations (1)

Unknown

RECRUITING

Hiser Medical Group, Qingdao

All Listed Sponsors

lead

Qingdao Hiser Medical Group

OTHER